시장조사 보고서 : 세계의 혈전 용해 요법 시장예측 2021년-2026년

■ 영문 제목 : Global Thrombolytic Therapy Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02316 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 104 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 혈전 용해 요법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (약물 치료, 외과 치료, 기타)와 용도별 시장규모 (급성 심근 경색, 폐색 전증, 심정맥 혈전증, 카테터 폐색, 급성 허혈성 뇌졸중) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 혈전 용해 요법 시장 점유율
- 지역별 혈전 용해 요법 시장규모
- 주요지역의 종류별 시장규모 (약물 치료, 외과 치료, 기타)
- 주요지역의 용도별 시장규모 (급성 심근 경색, 폐색 전증, 심정맥 혈전증, 카테터 폐색, 급성 허혈성 뇌졸중)
- 미주의 혈전 용해 요법 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 혈전 용해 요법 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 혈전 용해 요법 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 혈전 용해 요법 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 혈전 용해 요법 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Roche, Boehringer Ingelheim, Mochida Pharmaceutical, NanJing Nanda Pharmaceutical, Wanhua Biochem, Tianjin Biochem Pharmaceutical, Livzon Pharmaceutical Group, Sedico Pharmaceuticals, Microbix, Syner-Med
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Thrombolytic Therapy will have significant change from previous year. By the most conservative estimates of global Thrombolytic Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 31150 million in 2020. Over the next five years the Thrombolytic Therapy market will register a 2.2% CAGR in terms of revenue, the global market size will reach US$ 33950 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Thrombolytic Therapy market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Drug Treatment
Surgical Treatment
Other Treatment
Drug treatment is the most commonly used type, with about 89.15% market share in 2019.

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Acute Myocardial Infarction
Pulmonary Embolism
Deep Vein Thrombosis
Blocking the Catheter
Acute Ischemic Stroke
Demand from the acute myocardial infarction accounts for the largest market share, being 36.9% in 2019.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche
Boehringer Ingelheim
Mochida Pharmaceutical
NanJing Nanda Pharmaceutical
Wanhua Biochem
Tianjin Biochem Pharmaceutical
Livzon Pharmaceutical Group
Sedico Pharmaceuticals
Microbix
Syner-Med

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Thrombolytic Therapy Market Size 2016-2026
2.1.2 Thrombolytic Therapy Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Thrombolytic Therapy Segment by Type
2.2.1 Drug Treatment
2.2.2 Drug Treatment
2.2.3 Other Treatment
2.3 Thrombolytic Therapy Market Size by Type
2.3.1 Global Thrombolytic Therapy Market Size CAGR by Type
2.3.2 Global Thrombolytic Therapy Market Size Market Share by Type (2016-2021)
2.4 Thrombolytic Therapy Segment by Application
2.4.1 Acute Myocardial Infarction
2.4.2 Pulmonary Embolism
2.4.3 Deep Vein Thrombosis
2.4.4 Blocking the Catheter
2.4.5 Acute Ischemic Stroke
2.5 Thrombolytic Therapy Market Size by Application
2.5.1 Global Thrombolytic Therapy Market Size CAGR by Application
2.5.2 Global Thrombolytic Therapy Market Size Market Share by Application (2016-2021)

3 Thrombolytic Therapy Market Size by Players
3.1 Thrombolytic Therapy Market Size Market Share by Players
3.1.1 Global Thrombolytic Therapy Revenue by Players (2019-2021E)
3.1.2 Global Thrombolytic Therapy Revenue Market Share by Players (2019-2021E)
3.2 Global Thrombolytic Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Thrombolytic Therapy by Regions
4.1 Thrombolytic Therapy Market Size by Regions (2016-2021)
4.2 Americas Thrombolytic Therapy Market Size Growth (2016-2021)
4.3 APAC Thrombolytic Therapy Market Size Growth (2016-2021)
4.4 Europe Thrombolytic Therapy Market Size Growth (2016-2021)
4.5 Middle East & Africa Thrombolytic Therapy Market Size Growth (2016-2021)

5 Americas
5.1 Americas Thrombolytic Therapy Market Size by Country (2016-2021)
5.2 Americas Thrombolytic Therapy Market Size by Type (2016-2021)
5.3 Americas Thrombolytic Therapy Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Thrombolytic Therapy Market Size by Region (2016-2021)
6.2 APAC Thrombolytic Therapy Market Size by Type (2016-2021)
6.3 APAC Thrombolytic Therapy Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Thrombolytic Therapy by Country (2016-2021)
7.2 Europe Thrombolytic Therapy Market Size by Type (2016-2021)
7.3 Europe Thrombolytic Therapy Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Thrombolytic Therapy by Region (2016-2021)
8.2 Middle East & Africa Thrombolytic Therapy Market Size by Type (2016-2021)
8.3 Middle East & Africa Thrombolytic Therapy Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Thrombolytic Therapy Market Forecast
10.1 Global Thrombolytic Therapy Forecast by Regions (2021-2026)
10.1.1 Global Thrombolytic Therapy Forecast by Regions (2021-2026)
10.1.2 Americas Thrombolytic Therapy Forecast
10.1.3 APAC Thrombolytic Therapy Forecast
10.1.4 Europe Thrombolytic Therapy Forecast
10.1.5 Middle East & Africa Thrombolytic Therapy Forecast
10.2 Americas Thrombolytic Therapy Forecast by Countries (2021-2026)
10.2.1 United States Thrombolytic Therapy Market Forecast
10.2.2 Canada Thrombolytic Therapy Market Forecast
10.2.3 Mexico Thrombolytic Therapy Market Forecast
10.2.4 Brazil Thrombolytic Therapy Market Forecast
10.3 APAC Thrombolytic Therapy Forecast by Region (2021-2026)
10.3.1 China Thrombolytic Therapy Market Forecast
10.3.2 Japan Thrombolytic Therapy Market Forecast
10.3.3 Korea Thrombolytic Therapy Market Forecast
10.3.4 Southeast Asia Thrombolytic Therapy Market Forecast
10.3.5 India Thrombolytic Therapy Market Forecast
10.3.6 Australia Thrombolytic Therapy Market Forecast
10.4 Europe Thrombolytic Therapy Forecast by Country (2021-2026)
10.4.1 Germany Thrombolytic Therapy Market Forecast
10.4.2 France Thrombolytic Therapy Market Forecast
10.4.3 UK Thrombolytic Therapy Market Forecast
10.4.4 Italy Thrombolytic Therapy Market Forecast
10.4.5 Russia Thrombolytic Therapy Market Forecast
10.5 Middle East & Africa Thrombolytic Therapy Forecast by Region (2021-2026)
10.5.1 Egypt Thrombolytic Therapy Market Forecast
10.5.2 South Africa Thrombolytic Therapy Market Forecast
10.5.3 Israel Thrombolytic Therapy Market Forecast
10.5.4 Turkey Thrombolytic Therapy Market Forecast
10.5.5 GCC Countries Thrombolytic Therapy Market Forecast
10.6 Global Thrombolytic Therapy Forecast by Type (2021-2026)
10.7 Global Thrombolytic Therapy Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Thrombolytic Therapy Product Offered
11.1.3 Roche Thrombolytic Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Thrombolytic Therapy Product Offered
11.2.3 Boehringer Ingelheim Thrombolytic Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Boehringer Ingelheim Main Business Overview
11.2.5 Boehringer Ingelheim Latest Developments
11.3 Mochida Pharmaceutical
11.3.1 Mochida Pharmaceutical Company Information
11.3.2 Mochida Pharmaceutical Thrombolytic Therapy Product Offered
11.3.3 Mochida Pharmaceutical Thrombolytic Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Mochida Pharmaceutical Main Business Overview
11.3.5 Mochida Pharmaceutical Latest Developments
11.4 NanJing Nanda Pharmaceutical
11.4.1 NanJing Nanda Pharmaceutical Company Information
11.4.2 NanJing Nanda Pharmaceutical Thrombolytic Therapy Product Offered
11.4.3 NanJing Nanda Pharmaceutical Thrombolytic Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 NanJing Nanda Pharmaceutical Main Business Overview
11.4.5 NanJing Nanda Pharmaceutical Latest Developments
11.5 Wanhua Biochem
11.5.1 Wanhua Biochem Company Information
11.5.2 Wanhua Biochem Thrombolytic Therapy Product Offered
11.5.3 Wanhua Biochem Thrombolytic Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Wanhua Biochem Main Business Overview
11.5.5 Wanhua Biochem Latest Developments
11.6 Tianjin Biochem Pharmaceutical
11.6.1 Tianjin Biochem Pharmaceutical Company Information
11.6.2 Tianjin Biochem Pharmaceutical Thrombolytic Therapy Product Offered
11.6.3 Tianjin Biochem Pharmaceutical Thrombolytic Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Tianjin Biochem Pharmaceutical Main Business Overview
11.6.5 Tianjin Biochem Pharmaceutical Latest Developments
11.7 Livzon Pharmaceutical Group
11.7.1 Livzon Pharmaceutical Group Company Information
11.7.2 Livzon Pharmaceutical Group Thrombolytic Therapy Product Offered
11.7.3 Livzon Pharmaceutical Group Thrombolytic Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Livzon Pharmaceutical Group Main Business Overview
11.7.5 Livzon Pharmaceutical Group Latest Developments
11.8 Sedico Pharmaceuticals
11.8.1 Sedico Pharmaceuticals Company Information
11.8.2 Sedico Pharmaceuticals Thrombolytic Therapy Product Offered
11.8.3 Sedico Pharmaceuticals Thrombolytic Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Sedico Pharmaceuticals Main Business Overview
11.8.5 Sedico Pharmaceuticals Latest Developments
11.9 Microbix
11.9.1 Microbix Company Information
11.9.2 Microbix Thrombolytic Therapy Product Offered
11.9.3 Microbix Thrombolytic Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Microbix Main Business Overview
11.9.5 Microbix Latest Developments
11.10 Syner-Med
11.10.1 Syner-Med Company Information
11.10.2 Syner-Med Thrombolytic Therapy Product Offered
11.10.3 Syner-Med Thrombolytic Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Syner-Med Main Business Overview
11.10.5 Syner-Med Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Thrombolytic Therapy Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Drug Treatment
Table 3. Major Players of Surgical Treatment
Table 4. Major Players of Other Treatment
Table 5. Thrombolytic Therapy Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Thrombolytic Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Thrombolytic Therapy Market Size Market Share by Type (2016-2021)
Table 8. Thrombolytic Therapy Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Thrombolytic Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Thrombolytic Therapy Market Size Market Share by Application (2016-2021)
Table 11. Global Thrombolytic Therapy Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Thrombolytic Therapy Revenue Market Share by Players (2019-2021E)
Table 13. Thrombolytic Therapy Key Players Head office and Products Offered
Table 14. Thrombolytic Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Thrombolytic Therapy Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Thrombolytic Therapy Market Size Market Share by Regions 2016-2021
Table 19. Americas Thrombolytic Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Thrombolytic Therapy Market Size Market Share by Country (2016-2021)
Table 21. Americas Thrombolytic Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Thrombolytic Therapy Market Size Market Share by Type (2016-2021)
Table 23. Americas Thrombolytic Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Thrombolytic Therapy Market Size Market Share by Application (2016-2021)
Table 25. APAC Thrombolytic Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Thrombolytic Therapy Market Size Market Share by Region (2016-2021)
Table 27. APAC Thrombolytic Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Thrombolytic Therapy Market Size Market Share by Type (2016-2021)
Table 29. APAC Thrombolytic Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Thrombolytic Therapy Market Size Market Share by Application (2016-2021)
Table 31. Europe Thrombolytic Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Thrombolytic Therapy Market Size Market Share by Country (2016-2021)
Table 33. Europe Thrombolytic Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Thrombolytic Therapy Market Size Market Share by Type (2016-2021)
Table 35. Europe Thrombolytic Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Thrombolytic Therapy Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Thrombolytic Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Thrombolytic Therapy Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Thrombolytic Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Thrombolytic Therapy Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Thrombolytic Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Thrombolytic Therapy Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Thrombolytic Therapy
Table 44. Key Application and Potential Industries of Thrombolytic Therapy
Table 45. Key Challenges of Thrombolytic Therapy
Table 46. Key Trends of Thrombolytic Therapy
Table 47. Global Thrombolytic Therapy Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Thrombolytic Therapy Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Thrombolytic Therapy Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Thrombolytic Therapy Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Thrombolytic Therapy Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Thrombolytic Therapy Market Size Market Share Forecast by Application (2021-2026)
Table 53. Roche Details, Company Type, Thrombolytic Therapy Area Served and Its Competitors
Table 54. Roche Thrombolytic Therapy Product Offered
Table 55. Roche Thrombolytic Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Roche Main Business
Table 57. Roche Latest Developments
Table 58. Boehringer Ingelheim Details, Company Type, Thrombolytic Therapy Area Served and Its Competitors
Table 59. Boehringer Ingelheim Thrombolytic Therapy Product Offered
Table 60. Boehringer Ingelheim Main Business
Table 61. Boehringer Ingelheim Thrombolytic Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Boehringer Ingelheim Latest Developments
Table 63. Mochida Pharmaceutical Details, Company Type, Thrombolytic Therapy Area Served and Its Competitors
Table 64. Mochida Pharmaceutical Thrombolytic Therapy Product Offered
Table 65. Mochida Pharmaceutical Main Business
Table 66. Mochida Pharmaceutical Thrombolytic Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Mochida Pharmaceutical Latest Developments
Table 68. NanJing Nanda Pharmaceutical Details, Company Type, Thrombolytic Therapy Area Served and Its Competitors
Table 69. NanJing Nanda Pharmaceutical Thrombolytic Therapy Product Offered
Table 70. NanJing Nanda Pharmaceutical Main Business
Table 71. NanJing Nanda Pharmaceutical Thrombolytic Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. NanJing Nanda Pharmaceutical Latest Developments
Table 73. Wanhua Biochem Details, Company Type, Thrombolytic Therapy Area Served and Its Competitors
Table 74. Wanhua Biochem Thrombolytic Therapy Product Offered
Table 75. Wanhua Biochem Main Business
Table 76. Wanhua Biochem Thrombolytic Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Wanhua Biochem Latest Developments
Table 78. Tianjin Biochem Pharmaceutical Details, Company Type, Thrombolytic Therapy Area Served and Its Competitors
Table 79. Tianjin Biochem Pharmaceutical Thrombolytic Therapy Product Offered
Table 80. Tianjin Biochem Pharmaceutical Main Business
Table 81. Tianjin Biochem Pharmaceutical Thrombolytic Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Tianjin Biochem Pharmaceutical Latest Developments
Table 83. Livzon Pharmaceutical Group Details, Company Type, Thrombolytic Therapy Area Served and Its Competitors
Table 84. Livzon Pharmaceutical Group Thrombolytic Therapy Product Offered
Table 85. Livzon Pharmaceutical Group Main Business
Table 86. Livzon Pharmaceutical Group Thrombolytic Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. Livzon Pharmaceutical Group Latest Developments
Table 88. Sedico Pharmaceuticals Details, Company Type, Thrombolytic Therapy Area Served and Its Competitors
Table 89. Sedico Pharmaceuticals Thrombolytic Therapy Product Offered
Table 90. Sedico Pharmaceuticals Main Business
Table 91. Sedico Pharmaceuticals Thrombolytic Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. Sedico Pharmaceuticals Latest Developments
Table 93. Microbix Details, Company Type, Thrombolytic Therapy Area Served and Its Competitors
Table 94. Microbix Thrombolytic Therapy Product Offered
Table 95. Microbix Main Business
Table 96. Microbix Thrombolytic Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. Microbix Latest Developments
Table 98. Syner-Med Details, Company Type, Thrombolytic Therapy Area Served and Its Competitors
Table 99. Syner-Med Thrombolytic Therapy Product Offered
Table 100. Syner-Med Main Business
Table 101. Syner-Med Thrombolytic Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 102. Syner-Med Latest Developments
List of Figures
Figure 1. Thrombolytic Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Thrombolytic Therapy Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Thrombolytic Therapy Market Size Market Share by Type in 2020
Figure 7. Thrombolytic Therapy in Acute Myocardial Infarction
Figure 8. Global Thrombolytic Therapy Market: Acute Myocardial Infarction (2016-2021) & ($ Millions)
Figure 9. Thrombolytic Therapy in Pulmonary Embolism
Figure 10. Global Thrombolytic Therapy Market: Pulmonary Embolism (2016-2021) & ($ Millions)
Figure 11. Thrombolytic Therapy in Deep Vein Thrombosis
Figure 12. Global Thrombolytic Therapy Market: Deep Vein Thrombosis (2016-2021) & ($ Millions)
Figure 13. Thrombolytic Therapy in Blocking the Catheter
Figure 14. Global Thrombolytic Therapy Market: Blocking the Catheter (2016-2021) & ($ Millions)
Figure 15. Thrombolytic Therapy in Acute Ischemic Stroke
Figure 16. Global Thrombolytic Therapy Market: Acute Ischemic Stroke (2016-2021) & ($ Millions)
Figure 17. Global Thrombolytic Therapy Market Size Market Share by Application in 2020
Figure 18. Global Thrombolytic Therapy Revenue Market Share by Player in 2020
Figure 19. Global Thrombolytic Therapy Market Size Market Share by Regions (2016-2021)
Figure 20. Americas Thrombolytic Therapy Market Size 2016-2021 ($ Millions)
Figure 21. APAC Thrombolytic Therapy Market Size 2016-2021 ($ Millions)
Figure 22. Europe Thrombolytic Therapy Market Size 2016-2021 ($ Millions)
Figure 23. Middle East & Africa Thrombolytic Therapy Market Size 2016-2021 ($ Millions)
Figure 24. Americas Thrombolytic Therapy Market Size Market Share by Country in 2020
Figure 25. Americas Thrombolytic Therapy Market Size Market Share by Type in 2020
Figure 26. Americas Thrombolytic Therapy Market Size Market Share by Application in 2020
Figure 27. United States Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 28. Canada Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 29. Mexico Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 30. APAC Thrombolytic Therapy Market Size Market Share by Regions in 2020
Figure 31. APAC Thrombolytic Therapy Market Size Market Share by Type in 2020
Figure 32. APAC Thrombolytic Therapy Market Size Market Share by Application in 2020
Figure 33. China Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 34. Japan Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 35. Korea Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 36. Southeast Asia Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 37. India Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 38. Australia Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 39. Europe Thrombolytic Therapy Market Size Market Share by Country in 2020
Figure 40. Europe Thrombolytic Therapy Market Size Market Share by Type in 2020
Figure 41. Europe Thrombolytic Therapy Market Size Market Share by Application in 2020
Figure 42. Germany Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 43. France Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 44. UK Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 45. Italy Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 46. Russia Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 47. Middle East & Africa Thrombolytic Therapy Market Size Market Share by Region in 2020
Figure 48. Middle East & Africa Thrombolytic Therapy Market Size Market Share by Type in 2020
Figure 49. Middle East & Africa Thrombolytic Therapy Market Size Market Share by Application in 2020
Figure 50. Egypt Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 51. South Africa Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 52. Israel Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 53. Turkey Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 54. GCC Country Thrombolytic Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 55. Americas Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 56. APAC Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 57. Europe Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 58. Middle East & Africa Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 59. United States Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 60. Canada Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 61. Mexico Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 62. Brazil Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 63. China Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 64. Japan Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 65. Korea Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 66. Southeast Asia Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 67. India Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 68. Australia Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 69. Germany Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 70. France Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 71. UK Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 72. Italy Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 73. Russia Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 74. Spain Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 75. Egypt Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 76. South Africa Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 77. Israel Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 78. Turkey Thrombolytic Therapy Market Size 2021-2026 ($ Millions)
Figure 79. GCC Country Thrombolytic Therapy Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 혈전 용해 요법 시장예측 2021년-2026년] (코드 : LPI-2201K02316) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 혈전 용해 요법 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 줄기 세포 치료 시장예측 2021년-2026년
LPI-2201K02308 / LP Information / 2021년 12월 / 본 조사보고서는 줄기 세포 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Stem Cell Therapy will have significant change from previous year. By the most conservative estimates of global Stem Cell Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 387.3 million in...

세계의 혈우병 유전자 치료 시장예측 2021년-2026년
LPI-2201K00120 / LP Information / 2021년 12월 / 본 조사보고서는 혈우병 유전자 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Hemophilia Gene Therapy will have significant change from previous year. By the most conservative estimates of global Hemophilia Gene Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 플라즈마 요법 시장예측 2021년-2026년
LPI-2201K02280 / LP Information / 2021년 12월 / 본 조사보고서는 플라즈마 요법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Plasma Therapy will have significant change from previous year. By the most conservative estimates of global Plasma Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 239.8 million in 2020. Over...

세계의 사운드 테라피 시장예측 2021년-2026년
LPI-2201K02303 / LP Information / 2021년 12월 / 본 조사보고서는 사운드 테라피의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Sound Therapy will have significant change from previous year. By the most conservative estimates of global Sound Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 내추럴 킬러 세포 치료법 시장예측 2021년-2026년
LPI-2201K02238 / LP Information / 2021년 12월 / 본 조사보고서는 내추럴 킬러 세포 치료법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Natural Killer Cell Therapy will have significant change from previous year. By the most conservative estimates of global Natural Killer Cell Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 201.5...

세계의 혈우병 A 및 B 재조합 인자 대체 요법 시장예측 2021년-2026년
LPI-2201K00119 / LP Information / 2021년 12월 / 본 조사보고서는 혈우병 A 및 B 재조합 인자 대체 요법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아,...According to this latest study, the 2021 growth of Hemophilia A and B Recombinant Factor Replacement Therapy will have significant change from previous year. By the most conservative estimates of global Hemophilia A and B Recombinant Factor Replacement Therapy market size (most likely outcome) will be a year-over-year revenue growth...

세계의 조직 재생 요법 시장예측 2021년-2026년
LPI-2201K02318 / LP Information / 2021년 12월 / 본 조사보고서는 조직 재생 요법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Tissue Regenerative Therapy will have significant change from previous year. By the most conservative estimates of global Tissue Regenerative Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in...